Back to Trades
Sell4
Heartflow, Inc.
HTFL
Total Value
$58.9M
Net $58.9M sold
Sales
$58.9M
4 transactions
Company Information
- Company Name
- Heartflow, Inc.
- Ticker Symbol
- HTFL
- CIK
- 0001464521
Insider Information
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Apr 30, 2026
- Transaction Date
- Apr 28, 2026
- Accession Number
- 0001193125-26-198593
- Form Type
- 4
- Net Trading Amount
- -$58.9M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 28, 2026 | Common Stock | 254,110 | $30.51 | Sale | $7.8M |
| Apr 29, 2026 | Common Stock | 797,133 | $29.37 | Sale | $23.4M |
| Apr 30, 2026 | Common Stock | 892,533 | $29.18 | Sale | $26.0M |
| Apr 30, 2026 | Common Stock | 56,224 | $30.05 | Sale | $1.7M |
Footnotes
- (F1)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.50 to $31.46, inclusive. The reporting person undertakes to provide to Heartflow, Inc., any security holder of Heartflow, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) of this Form 4.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.69, inclusive.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.995, inclusive.
- (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.19, inclusive.
- (F5)Represents securities held directly by BCLS Fund III Investments, LP ("BCLS Fund III Investments").
- (F6)Bain Capital Life Sciences Investors, LLC ("BCLSI") is the manager of Bain Capital Life Sciences III General Partner, LLC ("BCLS Fund III GP"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. ("BCLS Fund III"), which is the managing member of BCLS Fund III Investments GP, LLC ("BCLS Fund III Investments GP"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.